Infrared Images for Spinal Cord Stimulation in Complex Regional Pain Syndrome Patients
Launched by HOSPITAL FOR SPECIAL SURGERY, NEW YORK · Mar 9, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how infrared imaging can help monitor the effects of spinal cord stimulation (SCS) on patients with Complex Regional Pain Syndrome (CRPS). The main goal is to see if thermal images can show changes in the nervous system activity of the affected limb before and after the treatment. Researchers want to find out if these images can help understand how well the SCS is working, especially in relation to pain levels and quality of life for patients.
To participate, individuals must be between 18 and 85 years old and have been experiencing CRPS symptoms for at least three months without success from other treatments. Participants will have thermal images taken of their feet and will fill out questionnaires about their pain and quality of life. The trial is currently recruiting, and it’s important to note that certain conditions, such as infections or other specific nerve disorders, may exclude individuals from participating. This study aims to provide valuable insights into managing CRPS and improving treatment outcomes.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • The patient is between 18 and 85 years old
- • Providing CRPS diagnostic criteria by using the Budapest Clinical Diagnostic Criteria.
- • The patient has had pain and other symptoms for more than 3 months
- • Not responding to conventional medical treatments and multidisciplinary approach
- • High NRS detection in pain assessment despite appropriate treatment (NRS= and \> 6/10).
- • Pain causing a limitation in the patient's functional capacity despite appropriate treatment.
- Exclusion Criteria:
- • Patients with suspected disc herniation, spinal stenosis, myelopathy, and suspected radiculopathy in detailed examinations and examinations (MRI, CT).
- • Systemic or local infection
- • Coagulation disorders
- • History of allergy to contrast material
- • Malignancy
- • Pregnancy
- • Uncontrollable medical and psychiatric condition
- • The patients diagnosed with dysautonomia, sympathetic dysfunction other than CRPS (such as Raynaud disease or Buerger disease), sweating disorders other than CRPS (such as acquired idiopathic generalized anhidrosis), and patients
About Hospital For Special Surgery, New York
The Hospital for Special Surgery (HSS) in New York is a world-renowned institution specializing in orthopedic surgery, rheumatology, and rehabilitation. Recognized for its commitment to advancing medical research and improving patient outcomes, HSS serves as a leading clinical trial sponsor, facilitating innovative studies that explore cutting-edge treatments and therapies. With a team of expert clinicians and researchers, HSS aims to enhance clinical practices through rigorous scientific inquiry, ultimately contributing to the advancement of musculoskeletal health and patient care on a global scale.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Patients applied
Trial Officials
Semih Gungor, MD
Principal Investigator
Hospital for Special Surgery, New York
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials